Tellescope
PrivateLast Round
Early Funding
Jan 1, 2022
Total Funding Raised
$120,000
Company Overview
Tellescope is a digital health company that provides a HIPAA-compliant patient relationship management platform for digital health startups and clinics to streamline patient engagement and care operations.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, EHR & EMR, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tellescope Comparables
Compare Tellescope with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OhMD | 83% | |
| Spruce Health | 81% | |
| Healee | 81% | |
Tellescope Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 1, 2022 | ||||
| Accelerator | Aug 31, 2020 |
Key People
Founding team and executive leadership
Tellescope Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| UnitedHealthcare Accelerator | Accelerator |
| StartUp Health | Early Funding, Accelerator |
Tellescope Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tellescope's valuation, stock price, and market status.